Variability of interactions between neuroendocrine immunological functions physiological aging and dementia of the Alzheimer's type

Annals of the New York Academy of Sciences

Volumn 917, Issue , 2000, Pages 582-596

  Ferrari, E ^a   Fioravanti, M ^a   Magri, F ^a   Solerte, S B ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; DEXAMETHASONE; GAMMA INTERFERON; GROWTH HORMONE; HYDROCORTISONE; INTERLEUKIN 2; MELATONIN; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGING; ALZHEIMER DISEASE; COGNITION; CONFERENCE PAPER; CYTOKINE RELEASE; HIPPOCAMPUS; HORMONE RELEASE; HUMAN; HYPOPHYSIS ADRENAL SYSTEM; IMMUNE SYSTEM; IMMUNOREGULATION; NATURAL KILLER CELL; NERVE DEGENERATION; NEUROENDOCRINE SYSTEM; PATHOPHYSIOLOGY; TEMPORAL LOBE;

EID: 0033670376     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2000.tb05424.x     Document Type: Conference Paper

References (54)

1. The neuroendocrinology of stress and aging: The glucocorticoid cascade hypothesis
2. The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis
3. Effects of aging on endocrine and neuroendocrine rhythms in humans
4. Neuroendocrine correlates of the aging brain in humans
5. Changes in endocrine circadian rhythms as markers of physiological and pathological brain aging
6. Growth hormone/insulin-like growth factor-I axis in aging: A summary of a National Institutes of Aging-sponsored symposium
7. Aging and the adrenal cortex
8. Association between changes in adrenal secretion and cerebral morphometric correlates in normal aging and senile dementia
9. Inflammatory mechanism in Alzheimer's disease: Implications for therapy
10. Correlation of cytokine secretion by mononuclear cells of Alzheimer patients and their disease stage
11. Neuroimmune mechanism in Alzheimer's disease pathogenesis
12. Neuroautoimmunity: Pathogenetic implications for Alzheimer's disease
13. Enhanced cytotoxic rersponse of natural killer cells to IL-2 in Alzheimer's disease
14. Excitatory pattern of γ-interferon on natural killer cell activity in senile dementia of the Alzheimer's type
15. Increased natural killer cell cytotoxicity in Alzheimer's disease may involve protein kinase C dysregulation
16. The role of tumor necrosis factor, interleukin 6, interferon-γ and inducible nitric oxide synthase in the development and pathology of the nervous system
17. A molecular basis for bidirectional communication between the immune and neuroendocrine systems
18. Cytokines and endocrine function: An interaction between the immune and neuroendocrine systems
19. Hormonal activities of cytokines
20. The immunoneuroendocrine role of melatonin
21. Induction by cytokines of the pattern of pituitary hormone secretion in infection
22. Endocrine-paracrine interaction in communication between the immune and endocrine systems. Activation of the hypothalamic-pituitary-adrenal axis in inflammation
23. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation
24. Immuno-neuro-endocrine interactions: Facts and hypotheses
25. Prolonged glucocorticoid exposure reduces hippocampal neuron number: Implications for aging
26. Glucocorticoid-induced impairment in declarative memory performance in adult humans
27. Glucocorticoid hypersecretion and the age-impaired hippocampus: Cause or effect?
28. Stress hormones and brain aging: Adding injury to insult?
29. Cortisol levels during human aging predict hippocampal atrophy and memory deficits
30. The acute effects of corticosteroids on cognition: Integration of animal and human model studies
31. Interperson variability but intraperson stability of baseline plasma cortisol concentrations, and its relation to feedback sensitivity of the hypothalamo-pituitary-adrenal axis to a low dose of dexamethasone in elderly individuals
32. Admission criteria for immunogerontological studies in man: The SENIEUR protocol
33. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA workgroup under the auspices of Department of Healthy and Human Services Task Force on Alzheimer's disease
34. Multiinfarct dementia: A cause of mental deterioration in the elderly
35. Minimental state. A practical method for grading the cognitive state of patients for the clinician
36. Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer's disease
37. Chronobiology
38. Inferential statistical methods for estimating and comparing cosinor parameters
39. An enzyme-release assay for natural cytotoxicity
40. Spontaneous human lymphocyte mediated cytotoxicity against tumor target cells. A short review
41. Rediscovering an old friend, IGF - I: Potential use in the treatment of neurodegenerative diseases
42. Insulin-like growth factor I protects and rescues hippocampal neurons against beta-amyloid and human amylin-induced toxicity
43. Tumor necrosis factor (cachectin) in an endogenous pyrogen and induces production of interleukin 1
44. Adrenocorticotropin (ACTH) and non-ACTH-mediated regulation of the adrenal cortex: Neural and immune inputs
45. Cachectin alters anterior pituitary hormone release by direct action in vitro
46. Tumor necrosis factor-alpha and interleukin-2 differentially affect hippocampal serotoninergic neurotransmission, behavioural activity, body temperature and hypothalamic-pituitary-adrenocortial axis activity in the rat
47. Adrenocortical cells are the site of secretion and action of insulin-like growth factors and TNF-α
48. Tumor necrosis factor α decreases, and interleukin-10 increases, the sensitivity of human monocytes to dexamethasone: Potential regulation of the glucocorticoid receptor
49. Decreased immunosuppressive effect of cortisol on natural killer cytotoxic activity in senile dementia of the Alzheimer's type
50. Cytokine mediated groth hormone release from cultured ovine pituitary cells
51. Tumor necrosis factor-α inhibits growth hormone secretion from cultured anterior pituitary cells
52. Tumor necrosis factor α inhibits the hormonal response of the pituitary gland to hypothalamic releasing factors
53. Effect of recombinant human γ-interferon on the release of anterior pituitary hormones